Amgen (AMGN) Presents Erenumab Data at AHS

June 8, 2017 4:33 PM EDT Send to a Friend
Amgen (NASDAQ: AMGN) today announced that it will present 19 scientific abstracts at the 59th Annual Scientific Meeting of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login